Copyright © DrugPatentWatch. Initially printed at
Annual Drug Patent Expirations for PATANASE
Patanase is a drug marketed by Novartis and is included in a single NDA. It’s obtainable from two suppliers. There are two patents defending this drug and one Paragraph IV problem.
Drug patent litigation for PATANASE.
The generic ingredient in PATANASE is olopatadine hydrochloride. Two suppliers are listed for this compound. Further particulars can be found on the olopatadine hydrochloride profile web page.
For extra data on how DrugPatentWatch can assist along with your pharmaceutical enterprise intelligence wants, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com
Make Higher Choices with DrugPatentWatch
Copyright © DrugPatentWatch. Initially printed at
